RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

Search

Aumann AG

Cerrado

11.94 3.11

Resumen

Variación precio

24h

Actual

Mínimo

11.58

Máximo

12.2

Métricas clave

By Trading Economics

Ingresos

-3.9M

5M

Ventas

-19M

61M

P/B

Media del Sector

8.327

42.612

BPA

0.407

Rentabilidad por dividendo

1.79

Margen de beneficio

8.283

Empleados

867

EBITDA

-4.1M

7.3M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+34.45% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.79%

2.27%

Próximas Ganancias

14 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-7.5M

179M

Apertura anterior

8.83

Cierre anterior

11.94

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Aumann AG Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

Aumann AG Esperado

Precio Objetivo

By TipRanks

34.45% repunte

Estimación a 12 meses

Media 16 EUR  34.45%

Máximo 16 EUR

Mínimo 16 EUR

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aumann AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

12.2 / 13.46Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Aumann AG

Aumann AG manufactures and sells specialized machines and production lines for components of electric and classic drive chain systems in Europe, the United States, Canada, Mexico, China, and internationally. It operates through E-Mobility and Classic segments. The E-Mobility segment offers specialized machinery and automated production lines for the automotive industry; e-traction engines, inverters, power-on-demand units, and electronic components; and energy storage and conversion systems, such as batteries and fuel cells. The Classic segment provides special machines and automated production lines for automotive, renewable energy, consumer electronics, household appliances, and other industries. Its solutions include systems to produce drive components, including transmission systems, assembled camshafts, camshaft modules, cylinder activation and deactivation modules, and components for valve control systems; and lightweight components that reduce CO2 emissions from combustion engine vehicles. This segment also offers automated manufacturing and assembly solutions; transportation equipment for the aerospace industry; maintenance, retrofit, transportation, and spare parts services; and measurements, prototyping and machining of components. Aumann AG was founded in 1936 and is headquartered in Beelen, Germany.